Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-5-10
pubmed:abstractText
Carbohydrate response element binding protein (ChREBP) is a Mondo family transcription factor that activates a number of glycolytic and lipogenic genes in response to glucose stimulation. We have previously reported that high glucose can activate the transcriptional activity of ChREBP independent of the protein phosphatase 2A (PP2A)-mediated increase in nuclear entry and DNA binding. Here, we found that formation of glucose-6-phosphate (G-6-P) is essential for glucose activation of ChREBP. The glucose response of GAL4-ChREBP is attenuated by D-mannoheptulose, a potent hexokinase inhibitor, as well as over-expression of glucose-6-phosphatase (G6Pase); kinetics of activation of GAL4-ChREBP can be modified by exogenously expressed GCK. Further metabolism of G-6-P through the two major glucose metabolic pathways, glycolysis and pentose-phosphate pathway, is not required for activation of ChREBP; over-expression of glucose-6-phosphate dehydrogenase (G6PD) diminishes, whereas RNAi knockdown of the enzyme enhances, the glucose response of GAL4-ChREBP, respectively. Moreover, the glucose analogue 2-deoxyglucose (2-DG), which is phosphorylated by hexokinase, but not further metabolized, effectively upregulates the transcription activity of ChREBP. In addition, over-expression of phosphofructokinase (PFK) 1 and 2, synergistically diminishes the glucose response of GAL4-ChREBP. These multiple lines of evidence support the conclusion that G-6-P mediates the activation of ChREBP.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-10868964, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-11470916, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-11698644, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-12590264, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-12684532, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-1315961, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-1356982, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-1370150, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-16375857, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-16644671, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-16705063, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-16873678, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-16891625, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-18193046, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-18436566, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-18591247, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-2026584, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-3300731, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-7758108, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-776171, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-7831398, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-8226928, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-9240931, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-9240934, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-9259982, http://linkedlifedata.com/resource/pubmed/commentcorrection/20382127-9267763
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1090-2104
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2010 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
7
pubmed:volume
395
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
395-400
pubmed:dateRevised
2011-7-28
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP).
pubmed:affiliation
Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural